Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Teva Received FDA Approval for Tasimelteon

Teva Received FDA Approval for Tasimelteon

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

December 13, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

Guggenheim Maintains Buy on Live Nation Entertainment, Lowers Price Target to $120

October 7, 9:24 AM

Guggenheim analyst Curry Baker maintains Live Nation Entertainment (NYSE:LYV) with a Buy and lowers the price target from $140 to $120.

April 9, 11:00 AM

In today’s rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to…

July 31, 10:01 AM

Amazon.Com, Inc (NASDAQ: AMZN) stock is trading higher Monday amid investors seeking updates on the

October 31, 6:15 AM

Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $120 to $85.